ACE2 and COVID-19: Therefore, reduced TMPRSS2 but increased ACE2 in response to chronic exposure (60 h) to genistein in inflamed Caco-2/TC7 cells could be considered beneficial in attenuating the risk of SARS-CoV-2 infection and COVID-19 pathophysiology (Figure 7).